ExcepGen
About:
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Website: https://www.excepgen.com/
Top Investors: RA Capital Management, Y Combinator, ZAKA VC, SV Angel, Apollo Projects
Description:
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
Total Funding Amount:
$4.18M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2018-01-01
Founders:
Barbara Mertins, Thomas Folliard
Number of Employees:
1-10
Last Funding Date:
2023-08-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai